Concern about the Food and Drug Administration's drug approval process

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:466 / 467
页数:2
相关论文
共 50 条
  • [21] THE DRUG APPROVAL PROCESS AT THE FOOD AND DRUG ADMINISTRATION - NEW BIOTECHNOLOGY AS A PARADIGM OF A SCIENCE-BASED ACTIVIST APPROACH
    MILLER, HI
    YOUNG, FE
    ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (03) : 655 - 657
  • [22] United States food and drug administration requirements for approval of generic drug products
    Meyer, MC
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 4 - 9
  • [23] Exploring the Food and Drug Administration's review and approval of Entresto (sacubitril/valsartan)
    Eadie, Ashley L.
    Brunt, Keith R.
    Herder, Matthew
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (03):
  • [24] Approval and access to caner drugs - U.S. Food and Drug Administration
    Pazdur, Richard
    Williams, Grant
    Johnson, John
    Farrell, Ann
    Dagher, Ramzi
    ANNALS OF ONCOLOGY, 2004, 15 : 9 - 9
  • [25] Medical Device Approval Process in China since the Introduction of the China Food and Drug Administration
    Lueddemann, Tobias
    Chang, Diqing
    Sahin, Sadik
    Lueth, Tim C.
    2016 IEEE Symposium on Product Compliance Engineering (ISPCE), 2016,
  • [26] Food and Drug Administration process for development and approval of drugs and radiopharmaceuticals: Treatments in urologic oncology
    Ning, Yang-Min
    Maher, V. Ellen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (03) : 137 - 142
  • [27] Dorsal root ganglion stimulation approval by the Food and Drug Administration: advice on evolving the process
    Deer, Timothy R.
    Pope, Jason E.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1123 - 1125
  • [28] How the Food and Drug Administration Drug Approval Process Relates to the Potential Approval of Intravenous Racemic Ketamine for Treatment-resistant Major Depression
    Preskorn, Sheldon H.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2024, 30 (02) : 134 - 138
  • [29] Oncology Drug Development and Approval of Systemic Anticancer Therapy by the US Food and Drug Administration
    Martell, Robert E.
    Sermer, David
    Getz, Kenneth
    Kaitin, Kenneth I.
    ONCOLOGIST, 2013, 18 (01): : 104 - 111
  • [30] Comparison of Oncology Drug Approval Between Health Canada and the US Food and Drug Administration
    Ezeife, Doreen A.
    Truong, Tony H.
    Heng, Daniel Y. C.
    Bourque, Sylvie
    Welch, Stephen A.
    Tang, Patricia A.
    CANCER, 2015, 121 (10) : 1688 - 1693